US 11279763
Integrin alpha 9 blockade suppresses lymphatic valve formation and promotes transplant survival
granted A61KA61K2039/505A61K45/06
Quick answer
US patent 11279763 (Integrin alpha 9 blockade suppresses lymphatic valve formation and promotes transplant survival) held by The Regents of the University of California expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K45/06, A61K9/0019, A61K9/0048